{"disease":{"id":"narrow-angle","name":"narrow angle"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04083742","title":"The Heidelberg Engineering ANTERION Anterior Segment Metrics Precision and Agreement Study","phase":"","overall_status":"COMPLETED","enrollment_count":59,"lead_sponsor_name":"Heidelberg Engineering GmbH","has_results":false},{"nct_id":"NCT05236439","title":"Study of a Cilioscleral Interposition Device (CID) SV22 in Patients With Primary Open Angle Glaucoma and Narrow Angle Glaucoma","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":57,"lead_sponsor_name":"Ciliatech","has_results":false},{"nct_id":"NCT06120621","title":"Combined VCST With Phacoemulsification Versus Phacoemulsification in Primary Angle Closure Glaucoma","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Mansoura University","has_results":false},{"nct_id":"NCT05625958","title":"Clinical Study Evaluating the Efficacy and Safety of CID v2.2 in Glaucoma Surgery","phase":"NA","overall_status":"RECRUITING","enrollment_count":29,"lead_sponsor_name":"Ciliatech","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}